iSpecimen Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period
iSpecimen Inc. (ISPC) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period of 338 shares for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod · last filed 2025-08-14
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-06-30 was 186.00 shares.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2025-03-31 was 152.00 shares.
- iSpecimen Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period for the quarter ending 2024-12-31 was 57.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period 12 month |
|---|---|---|---|---|
| 2025-06-30 | 186.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 338.00 shares 10-Q · filed 2025-08-14 | 395.00 shares derived: sum of 3 quarters · filed 2025-08-14 | |
| 2025-03-31 | 152.00 shares 10-Q · filed 2025-05-19 | 209.00 shares derived: sum of 2 quarters · filed 2025-08-14 | ||
| 2024-12-31 | 57.00 shares derived: 10-Q 12 month − 10-Q 9 month · filed 2025-08-14 | 1.80K shares 10-Q · filed 2025-08-14 | ||
| 2024-09-30 | 1.74K shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| OneMedNet Corp (ONMD) | $0.042B | ||
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |